Lc Bio Co Stock Current Valuation
| 290650 Stock | 20,700 400.00 1.90% |
Valuation analysis of LC Bio helps investors to measure LC Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that LC Bio's price fluctuation is very steady at this time. Calculation of the real value of LC Bio is based on 3 months time horizon. Increasing LC Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for LC Bio Co is useful when determining the fair value of the 290650 stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of LC Bio. Since LC Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 290650 Stock. However, LC Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20700.0 | Real 17388.0 | Hype 20700.0 | Naive 21938.82 |
The real value of 290650 Stock, also known as its intrinsic value, is the underlying worth of LC Bio Company, which is reflected in its stock price. It is based on LC Bio's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of LC Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence LC Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of LC Bio Co helps investors to forecast how 290650 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LC Bio more accurately as focusing exclusively on LC Bio's fundamentals will not take into account other important factors: LC Bio Co Company Current Valuation Analysis
LC Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current LC Bio Current Valuation | 758.79 B |
Most of LC Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LC Bio Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, LC Bio Co has a Current Valuation of 758.79 B. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
290650 Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LC Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LC Bio could also be used in its relative valuation, which is a method of valuing LC Bio by comparing valuation metrics of similar companies.LC Bio is currently under evaluation in current valuation category among related companies.
290650 Fundamentals
| Return On Equity | 13.13 | |||
| Return On Asset | 0.057 | |||
| Profit Margin | 0.32 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 758.79 B | |||
| Shares Owned By Insiders | 33.87 % | |||
| Shares Owned By Institutions | 6.94 % | |||
| Revenue | 45.68 B | |||
| Gross Profit | 19.56 B | |||
| EBITDA | 9.37 B | |||
| Net Income | 15.58 B | |||
| Cash And Equivalents | 9.47 B | |||
| Total Debt | 6.1 B | |||
| Cash Flow From Operations | 10.91 B | |||
| Number Of Employees | 74 | |||
| Beta | -0.12 | |||
| Market Capitalization | 513.81 B | |||
| Total Asset | 107.4 B | |||
| Z Score | 50.4 | |||
| Annual Yield | 0 % | |||
| Net Asset | 107.4 B |
About LC Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LC Bio Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LC Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LC Bio Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LC Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LC Bio's short interest history, or implied volatility extrapolated from LC Bio options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in LC Bio Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the LC Bio information on this page should be used as a complementary analysis to other LC Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for 290650 Stock analysis
When running LC Bio's price analysis, check to measure LC Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LC Bio is operating at the current time. Most of LC Bio's value examination focuses on studying past and present price action to predict the probability of LC Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LC Bio's price. Additionally, you may evaluate how the addition of LC Bio to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |